U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07543679) titled 'Objective Assessment of Skin Damage Using ADHELASKIN in Patients With Systemic Sclerosis' on April 14.
Brief Summary: Systemic sclerosis (SSc) is an autoimmune disease characterized by skin fibrosis, which clinically manifests as thickening, hardening, and loss of elasticity of the skin. Patients are typically classified as having diffuse cutaneous SSc (dcSSc) or limited cutaneous SSc (lcSSc) depending on the extent of skin fibrosis. The standard assessment of cutaneous sclerosis is based on the modified Rodnan skin score (mRSS), which consists of clinical palpation of 17 areas of the body, scored from 0 (normal) to 3 (severe scler...